KYAN Therapeutics Company
KYAN Therapeutics is a clinical-stage AI company leveraging its proprietary technology platforms to transform the way patients are treated.
Funding Status:
Seed
Industry:
End-to-End Drug Development
Estimated Revenue:
Less than $1M
Technology:
Artificial Intelligence, Biopharma, Biotechnology, Health Care, Life Science, Pharmaceutical, Therapeutics
Headquarters:
Singapore, Central Region, Singapore
Total Funding:
5000000.0
Last Funding Date:
2022-10-26
Last Funding Type:
Seed
Employee Number:
1-10
Investors Number:
3.0
Founded Date:
2014-06-10